This focused issue on Lung Emphysema is edited by Dr. Bassam Redwan, MD, from Department of Thoracic Surgery, Klinikum Westfalen, Lünen, Germany.
Bassam Redwan was born in 1983. He received the M.D. degree from the Medical University of Vienna, Vienna, Austria, in 2007. In February 2016, he became a board-certified Thoracic Surgeon. Between 2016 and 2018, he worked as Consultant for Thoracic Surgery at Klinikum Ibbenbueren, Helios University Hospital of Wuppertal and University Hospital of Muenster. Since October 2018, he became a Senior Consultant and Vice-Chief of Thoracic Surgery at the Department of Thoracic Surgery, Klinik am Park, Klinikum Westfalen, Luenen, Germany. His clinical and research scope of interest are extracorporeal lung support, lung cancer, vascular biology, pulmonary hypertension and lung emphysema.
Focused issue outline:
- Advances in imaging for lung emphysema
- Transpleural ventilation in patients with lung emphysema
- Lung volume reduction surgery (LVRS): from NETT to NIUVATS
- Endobronchial lung volume reduction (ELVR): status quo
- Anesthesia in patients with lung emphysema undergoing thoracic surgery
- Lung emphysema and lung cancer: what do we know about it?
- Role of inflammation in the pathogenesis of lung emphysema: what did we learn from murine models?
- Biomarkers of lung emphysema
- Molecular insights into lung emphysema and potential therapy
- Alpha-1-antitrypsin deficiency in lung emphysema patients
- Lung transplantation for patients with lung emphysema